Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longeveron Inc (NQ: LGVN ) 2.350 -0.110 (-4.47%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Longeveron Inc < Previous 1 2 3 4 Next > InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Reports on Q2 2024 Financial Results, Business Highlights August 15, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call August 06, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference July 29, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Closes on $9M Registered Direct Offering July 22, 2024 Via Investor Brand Network Exposures Product Safety 5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK July 19, 2024 Via AB Newswire Exposures Product Safety InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Expands Growing Telecommunications Sector Through New Subsidiary July 18, 2024 Via Investor Brand Network InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Enters into $9M Registered Direct Offering July 18, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Lomecel-B(TM) Granted Fast Track Designation for Treatment of Mild Alzheimer’s Disease July 17, 2024 Via Investor Brand Network Exposures Product Safety TechMediaBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Lomecel-B(TM) Granted RMAT Designation for the Treatment of Mild Alzheimer’s Disease July 10, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Elected New Board Member at Annual Stockholder Meeting July 10, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Strategic Board Appointment of Gene Therapy Pioneer Roger Hajjar, MD July 08, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Presentation at Virtual Life Sciences Investor Forum Made Available for Online Viewing June 21, 2024 Via Investor Brand Network Exposures Product Safety Life Science Virtual Investor Forum Presentations Now Available for Online Viewing June 21, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Life Sciences Virtual Investor Forum Agenda Announced for June 20th June 18, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for $4.4M, Present at Virtual Life Sciences Investor Forum June 17, 2024 Via Investor Brand Network Exposures Product Safety Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase June 17, 2024 EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END Via FinancialNewsMedia BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces CEO Participation in Emerging Growth Conference, Completion of Investigator Meeting for Phase 2b Clinical Trial June 11, 2024 Via Investor Brand Network Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase June 17, 2024 From FN Media Group LLC Via GlobeNewswire InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Participate in Upcoming Emerging Growth Virtual Conference June 10, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Launches New Business, Eyes Opportunity in Contract Manufacturing June 03, 2024 Via Investor Brand Network InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Set to Participate in Upcoming BIO International Convention 2024 May 28, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Releases Financial Report, Business Update for Q1 2024 May 15, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Releases Planned Transitions for Board of Directors May 13, 2024 Via Investor Brand Network Researchers Link Dietary Fats to Alzheimer’s Disease May 06, 2024 Via Investor Brand Network BioMedNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q1 2024 Financial Results, Earnings Conference Call/Webcast May 02, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Presenting at This Week’s Planet MicroCap Showcase April 29, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate in Upcoming Planet MicroCap Showcase April 26, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Closes on Multimillion-Dollar Warrant Exercise Offering, Public Offering April 19, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M April 17, 2024 Via Investor Brand Network New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People April 17, 2024 Via Investor Brand Network < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.